Indications and uses
For the temporary relief of pain associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritations. First aid to help prevent infection in minor cuts, scrapes and burns.
Blistex ® Foille ® Medicated First Aid Ointment
- Manufacturer
- Blistex Inc.
- Effective date
- 2024-12-11
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:42:37
Label at a glance#
ProductBlistex Foille Medicated First Aid
Active ingredientBenzocaine, Chloroxylenol
Label structure8 sections
Dosage and administration
Clean the affected area. Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily. Children under 2 years of age: consult a physician.
Storage and handling
Avoid contact with clothing. Foille may stain certain fabrics.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active ingredients | Purpose |
|---|---|
| Benzocaine 5.0 % (w/w) | External analgesic |
| Chloroxylenol 0.1 % (w/w) | Antiseptic |
Uses
- For the temporary relief of pain associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritations.
- First aid to help prevent infection in minor cuts, scrapes and burns.
Warnings
For external use only
When using this product
- Avoid contact with the eyes
Stop use and ask a doctor if
- condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days.
OTC - DO NOT USE SECTION
- Do not apply over large areas of the body. In case of deep or puncture wounds, animal bites, or serious burns, consult a doctor.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Clean the affected area.
- Adults and children 2 years of age and older: Apply to affected area not more than 3 to 4 times daily.
- Children under 2 years of age: consult a physician.
Other information
- Avoid contact with clothing. Foille may stain certain fabrics.
Inactive ingredients
beeswax, benzyl alcohol, calcium disodium EDTA, calcium hydroxide, ceresin, citric acid, eugenol, hydrogenated coconut oil, mono- and di-glycerides, PEG-32, purified water, sodium borate, sodium lauryl sulfate, zea mays (corn) oil
PRINCIPAL DISPLAY PANEL - 28 g Tube Carton
NDC 10157-9302-4
Foille®
EXTERNAL ANALGESIC / ANTISEPTIC
MEDICATED
FIRST AID OINTMENT
Fast, Soothing Relief Of Pain Due To:
Minor Cuts, Scrapes & Burns
Sunburn • Insect Bites
Net Wt.
1 oz. (28 g)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 199005 | benzocaine 5 % / chloroxylenol 0.1 % Topical Ointment | PSN | 4 |
| 213034 | Foille 5 % / 0.1 % Topical Ointment | PSN | 4 |
| 213034 | benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment [Foille] | SBD | 4 |
| 199005 | benzocaine 0.05 MG/MG / chloroxylenol 0.001 MG/MG Topical Ointment | SCD | 4 |
| 199005 | benzocaine 5 % / chloroxylenol 0.1 % Topical Ointment | SY | 4 |
| 213034 | Foille (benzocaine 5 % / chloroxylenol 0.1 % ) Topical Ointment | SY | 4 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10157-9302-3 | Blistex Foille Medicated First Aid | 1 in 1 CARTON | OINTMENT | 1 | 4 | |
| 10157-9302-3 | Blistex Foille Medicated First Aid | 14 g in 1 TUBE | OINTMENT | 14 | 4 | |
| 10157-9302-4 | Blistex Foille Medicated First Aid | 1 in 1 CARTON | OINTMENT | 1 | 4 | |
| 10157-9302-4 | Blistex Foille Medicated First Aid | 28 g in 1 TUBE | OINTMENT | 28 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10157-9302 | BLISTEX FOILLE MEDICATED FIRST AID (BENZOCAINE AND CHLOROXYLENOL) OINTMENT [BLISTEX INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241213_e2eca808-e97b-43e0-aa51-7025cc61c7a8.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzocaine | ACTIVE INGREDIENT | U3RSY48JW5 | 1 | |
| Chloroxylenol | ACTIVE INGREDIENT | 0F32U78V2Q | 1 | |
| Benzocaine | ACTIVE MOIETY | U3RSY48JW5 | 1 | |
| Chloroxylenol | ACTIVE MOIETY | 0F32U78V2Q | 1 | |
| benzyl alcohol | INACTIVE INGREDIENT | LKG8494WBH | 1 | |
| calcium hydroxide | INACTIVE INGREDIENT | PF5DZW74VN | 1 | |
| ceresin | INACTIVE INGREDIENT | Q1LS2UJO3A | 1 | |
| corn oil | INACTIVE INGREDIENT | 8470G57WFM | 1 | |
| edetate calcium disodium anhydrous | INACTIVE INGREDIENT | 8U5D034955 | 1 | |
| eugenol | INACTIVE INGREDIENT | 3T8H1794QW | 1 | |
| maleic anhydride | INACTIVE INGREDIENT | V5877ZJZ25 | 1 | |
| polyethylene glycol 1500 | INACTIVE INGREDIENT | 1212Z7S33A | 1 | |
| sodium borate | INACTIVE INGREDIENT | 91MBZ8H3QO | 1 | |
| sodium lauryl sulfate | INACTIVE INGREDIENT | 368GB5141J | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- Blistex Foille Medicated First Aid
- Benzocaine and Chloroxylenol
- Benzocaine
- Chloroxylenol
- corn oil
- HYDROGENATED COCONUT OIL
- yellow wax
- POLYETHYLENE GLYCOL 1600
- water
- benzyl alcohol
- GLYCERYL MONO- AND DIPALMITOSTEARATE
- ceresin
- sodium borate
- calcium hydroxide
- edetate calcium disodium anhydrous
- eugenol
- sodium lauryl sulfate
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10157-9302 | 10157-9302-4, 10157-9302-3 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ceresin | CERESIN | Q1LS2UJO3A | OINTMENT / TOPICAL | 1097 mg | ||
| sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| corn oil | CORN OIL | 8470G57WFM | CREAM / TOPICAL | NA | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| polyethylene glycol 1500 | POLYETHYLENE GLYCOL 1600 | 1212Z7S33A | SOLUTION / TOPICAL | 29.7 %w/w | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / SUBCUTANEOUS | ADJ PH | ||
| ceresin | CERESIN | Q1LS2UJO3A | OINTMENT / TOPICAL | 1097 mg | ||
| corn oil | CORN OIL | 8470G57WFM | CREAM / TOPICAL | NA | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRAVENOUS | 23 mg | ||
| sodium lauryl sulfate | SODIUM LAURYL SULFATE | 368GB5141J | OINTMENT / TOPICAL | 14 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION, SOLUTION / INTRAVASCULAR | 0.05 %w/v | ||
| corn oil | CORN OIL | 8470G57WFM | CREAM / TOPICAL | NA | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | OINTMENT / TOPICAL | 20 %w/w | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION, SOLUTION / INTRAVASCULAR | 0.05 %w/v | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION / INTRA-ARTERIAL | 23 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | CAPSULE, EXTENDED RELEASE / ORAL | 14 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | INJECTION / INTRAVENOUS | 3.7 mg | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| calcium hydroxide | CALCIUM HYDROXIDE | PF5DZW74VN | SUSPENSION / ORAL | ADJ PH | ||
| edetate calcium disodium anhydrous | EDETATE CALCIUM DISODIUM ANHYDROUS | 8U5D034955 | INJECTION, SOLUTION / INTRAVASCULAR | 0.05 %w/v | ||
| ceresin | CERESIN | Q1LS2UJO3A | OINTMENT / TOPICAL | 1097 mg | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | CREAM / TOPICAL | NA | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | CREAM / TOPICAL | NA | ||
| polyethylene glycol 1500 | POLYETHYLENE GLYCOL 1600 | 1212Z7S33A | SOLUTION / TOPICAL | 29.7 %w/w | ||
| sodium borate | SODIUM BORATE | 91MBZ8H3QO | CREAM / TOPICAL | NA | ||
| benzyl alcohol | BENZYL ALCOHOL | LKG8494WBH | OINTMENT / TOPICAL | 2.2 %w/w | ||
| polyethylene glycol 1500 | POLYETHYLENE GLYCOL 1600 | 1212Z7S33A | SOLUTION / TOPICAL | 29.7 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Blistex Foille Medicated First Aid | BENZOCAINE AND CHLOROXYLENOL | Blistex Inc. | e2eca808-e97b-43e0-aa51-7025cc61c7a8 | 2024-12-11 | Warnings | 10157-9302-3 10157-9302-4 10157-9302 10157930203 10157930204 78fbbd4f-548d-4b5a-8e15-2ae2a01a3592 e2eca808-e97b-43e0-aa51-7025cc61c7a8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.